31![Beneficiary’s Medicaid ID# Beneficiary’s Medicaid ID#](https://www.pdfsearch.io/img/dd5ad18246168a80db1c1cf02a04a771.jpg) | Add to Reading ListSource URL: ahca.myflorida.comLanguage: English - Date: 2014-06-04 16:23:20
|
---|
32![CLINICAL REVIEW Application Type[removed]Submission Number 022 Submission Code SE5 CLINICAL REVIEW Application Type[removed]Submission Number 022 Submission Code SE5](https://www.pdfsearch.io/img/80e6c825e479e67b4e680432c11cc2ce.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
33![sbd_smd_2006_aptivus_098651_e.doc sbd_smd_2006_aptivus_098651_e.doc](https://www.pdfsearch.io/img/c6806d6a2032ec1169021b31e5894710.jpg) | Add to Reading ListSource URL: hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:26:14
|
---|
34![Beneficiary’s Medicaid ID# Beneficiary’s Medicaid ID#](https://www.pdfsearch.io/img/6ca8ed68f24e4bd110a3f4ec1a37452c.jpg) | Add to Reading ListSource URL: www.fdhc.state.fl.usLanguage: English - Date: 2014-06-04 16:23:20
|
---|
35![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU](https://www.pdfsearch.io/img/656983486fb0cd37ce193593b42fb3ef.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:10:23
|
---|
36![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU](https://www.pdfsearch.io/img/7dcd4f23dbe3c25e711fe182b5da2049.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-05-07 12:26:46
|
---|
37![NDA[removed]S003 NDA[removed]S004 -4– PREZISTA™* (Tibotec, Inc.) NDA[removed]S003 NDA[removed]S004 -4– PREZISTA™* (Tibotec, Inc.)](https://www.pdfsearch.io/img/31903427e3e304b3abde7fe9191144c1.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:10:39
|
---|
38![Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet Zetia (ezetimibe) /Vytorin (ezetimibe/simvastatin) Aptivus (tipranavir) Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet Zetia (ezetimibe) /Vytorin (ezetimibe/simvastatin) Aptivus (tipranavir)](https://www.pdfsearch.io/img/d060da78ea2708029ef24c4a1fc66b6e.jpg) | Add to Reading ListSource URL: www.fda.gov |
---|
39![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) Tablet for Oral use HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) Tablet for Oral use](https://www.pdfsearch.io/img/89bc932500eeccac8e1130ac5a862c4a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-02-22 15:55:19
|
---|
40![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE. ](https://www.pdfsearch.io/img/c21168deca763c5dca1a419a56d23b57.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-02-22 15:55:22
|
---|